[The value of an intervention for improving secondary prevention in patients undergoing cardiac surgery]

Area of Science:

• Cardiology
• Healthcare Quality Improvement
• Pharmacotherapy

Background:

• Secondary prevention treatment in cardiac surgery patients is frequently underutilized.
• Effective post-operative pharmacotherapy is crucial for long-term patient outcomes.

Purpose of the Study:

• To implement and evaluate a hospital-based intervention aimed at increasing the uptake of secondary prevention medications in patients following cardiac surgery.
• To assess the impact of a structured reporting system on physician prescribing habits.

Main Methods:

• A hospital intervention was introduced, requiring cardiac surgery physicians to complete a detailed patient report before discharge.
• This report documented treatment indications, prescribed drugs, dosages, and reasons for non-prescription or alternative medicine use.
• Drug utilization rates were compared between the intervention year (2003) and the preceding year using retrospective data.

Main Results:

• The intervention led to significant absolute increases in the use of indicated secondary prevention drugs.
• Aspirin use increased by 13.4%, statins by 38.3%, angiotensin-converting enzyme inhibitors by 21.8%, and beta-blockers by 21.5%.
• These improvements were observed in patients who clinically required these medications.

Conclusions:

• A simple, cost-effective hospital intervention can substantially enhance the prescription of secondary prevention drugs for cardiac surgery patients.
• The structured reporting system proved effective in improving adherence to evidence-based pharmacotherapy guidelines.
• This strategy offers a practical approach to optimizing care for patients at high risk of cardiovascular events.